StonvexLoading…
StonvexStonvexStonvexCore line items from IQV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.15B | $16.31B | $11.95B | $7.85B |
Operating Income | $514.00M | $2.18B | $1.55B | $1.00B |
Net Income | $274.00M | $1.36B | $846.00M | $515.00M |
EPS (Diluted) | $1.61 | $7.84 | $4.86 | $2.94 |
Total Assets | $29.68B | $29.94B | $28.73B | $28.63B |
Total Liabilities | $23.33B | $23.31B | $22.44B | $22.85B |
Cash & Equivalents | $1.95B | $1.98B | $1.81B | $2.04B |
Free Cash Flow OCF − CapEx | $491.00M | $2.05B | $1.49B | $718.00M |
Shares Outstanding | 166.90M | 169.60M | 170.30M | 170.00M |